AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32798488 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib, dexamethasone, and daratumumab
Number of subjects: 0
Study 32798488 — intervention group
Group type: COMPARATOR
Intervention: Carfilzomib and dexamethasone
Number of subjects: 0
Study 36510328 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate practice intervention (three 30-min sessions with content experts)
Number of subjects: 60
Study 36510328 — intervention group
Group type: COMPARATOR
Intervention: Passive control
Number of subjects: 60
Study 36510328 — intervention group
Group type: EXPERIMENTAL
Intervention: Deliberate practice intervention
Number of subjects: 60
Study 32150484 — intervention group
Group type: EXPERIMENTAL
Intervention: Aster glehni Extract (AGE) 480 mg/day
Number of subjects: 0
Study 32150484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34181721 — intervention group
Group type: EXPERIMENTAL
Intervention: NiTi closed coil springs
Number of subjects: 64
Study 34181721 — intervention group
Group type: COMPARATOR
Intervention: Elastomeric chains
Number of subjects: 64
Study 33208327 — intervention group
Group type: EXPERIMENTAL
Intervention: iThermonitor (WT705)
Number of subjects: 526
Study 33208327 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous temperature monitoring with iThermonitor
Number of subjects: 526
Study 33208327 — intervention group
Group type: COMPARATOR
Intervention: Mercury thermometers (control)
Number of subjects: 526
Study 36049557 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral everolimus (days 1-3: 7.5 mg qd, days 4-5: 5.0 mg qd)
Number of subjects: 150
Study 36049557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 35790011 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine solution (TBS) 8 mg (0.4 ml) for cats 1.2 to 3 kg and 20 mg (1 ml) for cats >3 to 7.5 kg, applied topically 1–2 h prior to surgery.
Number of subjects: 228
Study 35790011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study 35790011 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine solution (TBS)
Number of subjects: 228
Study 32102803 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) in addition to usual treatment for 16 weeks
Number of subjects: 1
Study 32102803 — intervention group
Group type: COMPARATOR
Intervention: Talking control in addition to usual treatment for 16 weeks
Number of subjects: 1
Study 35193105 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice (400 mg nitrate in 70 ml volume)
Number of subjects: 70
Study 35193105 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 32304248 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTG from the tuberosity area (TG)
Number of subjects: 29
Study 32304248 — intervention group
Group type: COMPARATOR
Intervention: SCTG from the lateral palate (CG)
Number of subjects: 29
Study 35473735 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine (0.2 mg/kg body weight)
Number of subjects: 564
Study 35473735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 564
Study 33899735 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium high-density lipoprotein (HDL) particles
Number of subjects: 77
Study 33899735 — intervention group
Group type: EXPERIMENTAL
Intervention: Small HDL particles
Number of subjects: 77
Study 33899735 — intervention group
Group type: EXPERIMENTAL
Intervention: Smaller mean HDL particle diameter
Number of subjects: 77
Study 34979026 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (H2O2) gel applied to the cervical region (GI)
Number of subjects: 30
Study 34979026 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (H2O2) gel applied to the incisal region (GII)
Number of subjects: 30
Study 34979026 — intervention group
Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (H2O2) gel applied to the total facial surface (GIII)
Number of subjects: 30
Study 34979026 — intervention group
Group type: COMPARATOR
Intervention: 35% hydrogen peroxide (H2O2) gel applied to any site
Number of subjects: 30
Study 34234581 — intervention group
Group type: EXPERIMENTAL
Intervention: Early goal-directed therapy (EGDT) using FloTrac/EV1000 platform
Number of subjects: 86
Study 34234581 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 86
Study 33547951 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training in hypoxia (FiO2: 14.5%)
Number of subjects: 9
Study 33547951 — intervention group
Group type: COMPARATOR
Intervention: Endurance training in normoxia (FiO2: 20.9%)
Number of subjects: 9
Study 35349416 — intervention group
Group type: EXPERIMENTAL
Intervention: UIPAF patients (38 patients)
Number of subjects: 190
Study 35349416 — intervention group
Group type: COMPARATOR
Intervention: IPF patients (152 patients)
Number of subjects: 190
Study 34498135 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST) 3 times per week for 8 weeks
Number of subjects: 16
Study 34498135 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 16
Study 34498135 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST) and Control group (CG)
Number of subjects: 16
Study 34980256 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating heat and cold stimulation (HC)
Number of subjects: 20
Study 34980256 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat stimulation
Number of subjects: 20
Study 34980256 — intervention group
Group type: COMPARATOR
Intervention: Cold stimulation
Number of subjects: 20
Study 34980256 — intervention group
Group type: COMPARATOR
Intervention: No stimulation
Number of subjects: 20
Study 32449152 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based therapist-delivered cognitive behavioral therapy (CBT)
Number of subjects: 212
Study 32449152 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control (WL)
Number of subjects: 212
Study 35641124 — intervention group
Group type: EXPERIMENTAL
Intervention: ABX464 50 mg
Number of subjects: 60
Study 35641124 — intervention group
Group type: EXPERIMENTAL
Intervention: ABX464 100 mg
Number of subjects: 60
Study 35641124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32704050 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire including the Dutch Musculoskeletal Questionnaire and Modified Nordic Musculoskeletal Questionnaire
Number of subjects: 29547
Study 32704050 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertiary hospital workers
Number of subjects: 29547
Study 32704050 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinicians
Number of subjects: 29547
Study 32704050 — intervention group
Group type: EXPERIMENTAL
Intervention: Log-binomial regression analysis
Number of subjects: 29547
Study 35914662 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab 300 mg subcutaneously every 4 weeks for 24 weeks
Number of subjects: 10
Study 35914662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 34776121 — intervention group
Group type: EXPERIMENTAL
Intervention: Wellness Intervention for Smokers Living with HIV (WISH)
Number of subjects: 0
Study 34776121 — intervention group
Group type: COMPARATOR
Intervention: Standard care services offered through the National VA Quitline and SmokefreeVET texting program
Number of subjects: 0
Study 36398042 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate at 40 mg·kg‐1 of actual body weight
Number of subjects: 75
Study 36398042 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate at 40 mg·kg‐1 of corrected ideal body weight
Number of subjects: 75
Study 36398042 — intervention group
Group type: COMPARATOR
Intervention: Control group (no magnesium sulfate)
Number of subjects: 75
Study 36398042 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 75
Study 33073523 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg once daily for 13 weeks
Number of subjects: 26
Study 33073523 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 26
Study 34391006 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 treatment course of rTMS
Number of subjects: 70
Study 34391006 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 treatment courses of rTMS
Number of subjects: 70
Study 32730719 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot Group (RG) - accompanied by the robot
Number of subjects: 200
Study 32730719 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - without robot accompaniment
Number of subjects: 200
Study 35428258 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 85
Study 35428258 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY)
Number of subjects: 85
Study 33989444 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone group (n=129)
Number of subjects: 255
Study 33989444 — intervention group
Group type: COMPARATOR
Intervention: In-person group (n=126)
Number of subjects: 255
Study 32807294 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Intervention Group (SIG)
Number of subjects: 40
Study 32807294 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 40
Study 35901477 — intervention group
Group type: EXPERIMENTAL
Intervention: BurstDR stimulation
Number of subjects: 14
Study 35901477 — intervention group
Group type: COMPARATOR
Intervention: Tonic SCS
Number of subjects: 14
Study 34612083 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-Thumb Technique
Number of subjects: 78
Study 34612083 — intervention group
Group type: COMPARATOR
Intervention: Two-Finger Technique
Number of subjects: 78
Study 36204903 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine 6 mm apical plug
Number of subjects: 40
Study 36204903 — intervention group
Group type: COMPARATOR
Intervention: Negative control (calcium hydroxide)
Number of subjects: 40
Study 33547980 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 400 μg dose of anti-GnRH vaccine (G1)
Number of subjects: 35
Study 33547980 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 400 μg doses of anti-GnRH vaccine (G2)
Number of subjects: 35
Study 33547980 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - 1 mL saline 0.9%
Number of subjects: 35
Study 35599990 — intervention group
Group type: EXPERIMENTAL
Intervention: Online group intervention consisting of 12 weekly modules based on cognitive-behavioral methods
Number of subjects: 140
Study 35599990 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 140
Study 35599990 — intervention group
Group type: EXPERIMENTAL
Intervention: Online group intervention
Number of subjects: 140
Study 34936268 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb-separated moxibustion on navel combined with Ningmitai capsule
Number of subjects: 66
Study 34936268 — intervention group
Group type: COMPARATOR
Intervention: Ningmitai capsule
Number of subjects: 66
Study 33870812 — intervention group
Group type: EXPERIMENTAL
Intervention: Active-Repeated sprint in hypoxia (A-RSH)
Number of subjects: 72
Study 33870812 — intervention group
Group type: EXPERIMENTAL
Intervention: Team Sports-Repeated sprint in hypoxia (T-RSH)
Number of subjects: 72
Study 33870812 — intervention group
Group type: COMPARATOR
Intervention: Endurance-Repeated sprint in normoxia (E-RSN)
Number of subjects: 72
Study 34366282 — intervention group
Group type: EXPERIMENTAL
Intervention: CALM (telehealth intervention)
Number of subjects: 31
Study 34366282 — intervention group
Group type: COMPARATOR
Intervention: TAU (treatment-as-usual)
Number of subjects: 31
Study 35724759 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g intravenously)
Number of subjects: 319
Study 35724759 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study 35724759 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 319
Study 34028005 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading, prep guide, plus group discussion
Number of subjects: 0
Study 34028005 — intervention group
Group type: COMPARATOR
Intervention: Reading
Number of subjects: 0
Study 34028005 — intervention group
Group type: COMPARATOR
Intervention: Reading plus prep guide
Number of subjects: 0
Study 34028005 — intervention group
Group type: COMPARATOR
Intervention: Reading, prep guide, group discussion, plus clarifying lecture
Number of subjects: 0
Study 35132096 — intervention group
Group type: EXPERIMENTAL
Intervention: VNS ON
Number of subjects: 15
Study 35132096 — intervention group
Group type: EXPERIMENTAL
Intervention: VNS OFF
Number of subjects: 15
Study 35132096 — intervention group
Group type: EXPERIMENTAL
Intervention: taVNS
Number of subjects: 15
Study 34062224 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual Construct
Number of subjects: 9
Study 34062224 — intervention group
Group type: COMPARATOR
Intervention: Two-rod construct
Number of subjects: 9
Study 34062224 — intervention group
Group type: COMPARATOR
Intervention: Two-rod with satellite rod
Number of subjects: 9
Study 36071409 — intervention group
Group type: EXPERIMENTAL
Intervention: P013 (CinnaGen, Iran)
Number of subjects: 214
Study 36071409 — intervention group
Group type: COMPARATOR
Intervention: Reference pertuzumab (Perjeta, Roche, Switzerland)
Number of subjects: 214
Study 33169383 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 36
Study 33169383 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ketamine without intubation
Number of subjects: 36
Study 33169383 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaesthesia providers
Number of subjects: 36
Study 33169383 — intervention group
Group type: EXPERIMENTAL
Intervention: Confidence in skills
Number of subjects: 36
Study 33169383 — intervention group
Group type: EXPERIMENTAL
Intervention: Availability of essential drugs
Number of subjects: 36
Study 33169383 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative recovery
Number of subjects: 36
Study 33169383 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood bank availability
Number of subjects: 36
Study 35126950 — intervention group
Group type: EXPERIMENTAL
Intervention: High-quality care in addition to basic care
Number of subjects: 94
Study 35126950 — intervention group
Group type: COMPARATOR
Intervention: Basic care
Number of subjects: 94
Study 34236131 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC) for one hour daily for five weeks
Number of subjects: 116
Study 34236131 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 116
Study 32723507 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention (supervised exercise and nutritional support)
Number of subjects: 57
Study 32723507 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed intervention (home-based exercise after nutritional support)
Number of subjects: 57
Study 32723507 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention
Number of subjects: 57
Study 32723507 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed intervention
Number of subjects: 57
Study 33378835 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual training intervention
Number of subjects: 0
Study 34750291 — intervention group
Group type: EXPERIMENTAL
Intervention: V114 (15-valent pneumococcal conjugate vaccine)
Number of subjects: 302
Study 34750291 — intervention group
Group type: COMPARATOR
Intervention: PCV13 (licensed 13-valent PCV)
Number of subjects: 302
Study 34750291 — intervention group
Group type: EXPERIMENTAL
Intervention: V114
Number of subjects: 302
Study 34750291 — intervention group
Group type: COMPARATOR
Intervention: PCV13
Number of subjects: 302
Study 33666305 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg risperidone
Number of subjects: 21
Study 33666305 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg risperidone
Number of subjects: 21
Study 33666305 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 33157963 — intervention group
Group type: COMPARATOR
Intervention: Propofol (P group)
Number of subjects: 300
Study 33157963 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol combined with etomidate (PE1 group, volume ratio 1:1)
Number of subjects: 300
Study 33157963 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol combined with etomidate (PE2 group, volume ratio 2:1)
Number of subjects: 300
Study 33157963 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol combined with etomidate (PE1 group)
Number of subjects: 300
Study 33157963 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol combined with etomidate (PE2 group)
Number of subjects: 300
Study 36397211 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful eating + TAU
Number of subjects: 76
Study 36397211 — intervention group
Group type: COMPARATOR
Intervention: TAU alone
Number of subjects: 76
Study 34995176 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking Away Plus (Walking Away with annual group-based support and a mobile health intervention)
Number of subjects: 1366
Study 34995176 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking Away (Walking Away with annual group-based support)
Number of subjects: 1366
Study 34995176 — intervention group
Group type: COMPARATOR
Intervention: Control (information leaflet)
Number of subjects: 1366
Study 32414563 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention and follow‐up visits
Number of subjects: 1589
Study 32414563 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1589
Study 36242787 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-facilitated self-management intervention (PFSMI)
Number of subjects: 180
Study 36242787 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation group (PEG)
Number of subjects: 180
Study 36242787 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 180
Study 36251971 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine (120 µg/kg/min over 20 minutes)
Number of subjects: 18
Study 36251971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 32462791 — intervention group
Group type: COMPARATOR
Intervention: Standard SCS programming
Number of subjects: 25
Study 32462791 — intervention group
Group type: EXPERIMENTAL
Intervention: Differential Target Multiplexed SCS programming
Number of subjects: 25
Study 33987732 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT with 0.005% methylene blue and red LED (660 nm, four irradiation points, 90 s per point, power of 400 mW, 36 J per point, radiant exposure of 95 J/cm2, continuous wave)
Number of subjects: 45
Study 33987732 — intervention group
Group type: COMPARATOR
Intervention: Tongue scraping
Number of subjects: 45
Study 33987732 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue scraping and aPDT
Number of subjects: 45
Study 33987732 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 45
Study 34292199 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based lower back exercise intervention, performed at least twice a day, four times a week for 8 weeks
Number of subjects: 54
Study 34292199 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based lower back exercise intervention for older adults
Number of subjects: 54
Study 34292199 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based lower back exercise intervention for middle-aged adults
Number of subjects: 54
Study 32337738 — intervention group
Group type: EXPERIMENTAL
Intervention: Current use of antipsychotics
Number of subjects: 7084
Study 32337738 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent use of antipsychotics
Number of subjects: 7084
Study 32337738 — intervention group
Group type: EXPERIMENTAL
Intervention: Recent past use of antipsychotics
Number of subjects: 7084
Study 32337738 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotics discontinued >90 days
Number of subjects: 7084
Study 32337738 — intervention group
Group type: EXPERIMENTAL
Intervention: Current therapy of antipsychotics at >1 defined daily dose
Number of subjects: 7084
Study 36181120 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 869
Study 32076863 — intervention group
Group type: EXPERIMENTAL
Intervention: Gasless endoscopic selective lateral neck dissection via the anterior chest approach (ACA)
Number of subjects: 91
Study 32076863 — intervention group
Group type: COMPARATOR
Intervention: Conventional open surgery (OPEN)
Number of subjects: 91
Study 35797219 — intervention group
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 125 mg/m2 + gemcitabine
Number of subjects: 336
Study 35797219 — intervention group
Group type: COMPARATOR
Intervention: carboplatin
Number of subjects: 336
Study 35797219 — intervention group
Group type: COMPARATOR
Intervention: additional anthracycline-containing chemotherapy
Number of subjects: 336
Study 35797219 — intervention group
Group type: EXPERIMENTAL
Intervention: high sTILs
Number of subjects: 336
Study 33161116 — intervention group
Group type: COMPARATOR
Intervention: Active control group (Greenlight trial)
Number of subjects: 235
Study 33161116 — intervention group
Group type: EXPERIMENTAL
Intervention: Age of TV introduction
Number of subjects: 235
Study 33161116 — intervention group
Group type: EXPERIMENTAL
Intervention: Sociodemographic factors
Number of subjects: 235
Study 33161116 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier TV watching
Number of subjects: 235
Study 32390583 — intervention group
Group type: EXPERIMENTAL
Intervention: Video training (demonstration video by Emergency Preparedness Team)
Number of subjects: 20
Study 32390583 — intervention group
Group type: COMPARATOR
Intervention: In-person training (standard in-person demonstration by Emergency Preparedness Team member)
Number of subjects: 20
Study 32390583 — intervention group
Group type: EXPERIMENTAL
Intervention: Video training
Number of subjects: 20
Study 32390583 — intervention group
Group type: COMPARATOR
Intervention: In-person training
Number of subjects: 20
Study 35014613 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal oral vitamin D supplementation 1,20,000 IU/month for 12 months
Number of subjects: 220
Study 35014613 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal oral vitamin D supplementation 12,000 IU/month for 12 months
Number of subjects: 220
Study 33670285 — intervention group
Group type: EXPERIMENTAL
Intervention: GMO Free labels
Number of subjects: 434
Study 33670285 — intervention group
Group type: EXPERIMENTAL
Intervention: Contains GMOs labels
Number of subjects: 434